Among patients eligible for metabolic and bariatric surgery (MBS), glucagon-like peptide-1 receptor agonist (GLP-1 RA) ...

In patients with diabetes and multivessel CAD, ticagrelor fails to meet noninferiority criteria compared with prasugrel at 1-year post-PCI.

The new guidance includes recommendations for MRI and transvaginal ultrasonography in the evaluation of suspected endometriosis.

Topline data were announced from a phase 3 trial evaluating DTX301 (avalotcagene ontaparvovec) for the treatment of OTC deficiency.

Although the Graves disease treatment landscape remains challenging, emerging therapies could shift existing treatment ...

Deaths linked to pregnancy and childbirth fell slightly in the United States in 2024, according to a new study.

Oral semaglutide reduces risk for heart failure events among patients with T2D and preexisting heart failure, according to the SOUL trial.

Treatment with GLP-1 RAs for T2D and obesity is independently associated with an increased risk for osteoporosis, gout, and osteomalacia.

Patients with MDD exhibit significantly higher triglyceride levels, which correlate with worse functional impairment scores.

Severe hypothyroidism is associated with a high burden of systolic/diastolic ventricular dysfunction and myocardial deformation abnormalities.

Adults with osteoporosis who receive denosumab vs bisphosphonates may have a lower long-term risk of developing knee osteoarthritis.

Current smoking in GD is linked to higher TRAb levels, increased odds of orbitopathy, and higher 12-month relapse risk after drug withdrawal.